Growth Metrics

Item 9 Labs (INLB) Accumulated Expenses (2016 - 2023)

Item 9 Labs' Accumulated Expenses history spans 12 years, with the latest figure at $8.4 million for Q2 2023.

  • For Q2 2023, Accumulated Expenses rose 354.21% year-over-year to $8.4 million; the TTM value through Jun 2023 reached $8.4 million, up 354.21%, while the annual FY2022 figure was $2.1 million, 49.89% up from the prior year.
  • Accumulated Expenses reached $8.4 million in Q2 2023 per INLB's latest filing, up from $6.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $8.4 million in Q2 2023 to a low of $35000.0 in Q2 2019.
  • Average Accumulated Expenses over 5 years is $1.9 million, with a median of $1.4 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: soared 1971.99% in 2020, then crashed 34.26% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $103342.0 in 2019, then skyrocketed by 1971.99% to $2.1 million in 2020, then dropped by 24.67% to $1.6 million in 2021, then plummeted by 34.26% to $1.1 million in 2022, then soared by 690.98% to $8.4 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Accumulated Expenses are $8.4 million (Q2 2023), $6.4 million (Q1 2023), and $1.1 million (Q4 2022).